International consumer group slates drug companies' marketing practices

BMJ 2006; 333 doi: 10.1136/bmj.333.7557.14-b (Published 29 June 2006)
Cite this as: BMJ 2006;333:14.3

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Michael Day
  1. London

    Drug companies continue to pull the wool over the eyes of patients and doctors, concludes a new report from Consumers International. The report lambasts the industry for its lack of transparency and unscrupulous marketing.

    Consumers International has called on governments to rein in the industry's practices that “misinform consumers about the benefits of the drugs they are buying.”

    It warns that drug companies are adopting new ways to influence consumers, such as sponsoring patients' groups and funding disease awareness campaigns, as well as using old methods such as offering hospitality to medical experts or “opinion leaders.”

    Richard Lloyd, the …

    Access to the full text of this article requires a subscription or payment

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    THIS WEEK'S POLL